CRITERIA OF TUBERCULOSIS TREATMENT EFFICIENCY IN CHILDREN UNDER CURRENT CONDITIONS
https://doi.org/10.21292/2075-1230-2017-95-10-69-74
Abstract
The main objective of a phthisiologist following up and treating children and adolescents with local forms of tuberculosis is to achieve complete clinical cure with minimal remaining post-tuberculosis changes. Evaluation of treatment progress is important since it defines not only the duration of chemotherapy and follow-up but it also serves a prognostic criterion of stable clinical cure and prevention of relapse in the future. New criteria for evaluation of tuberculosis activity and clinical cure in children and adolescents were assessed. It was proved that Mantoux test could not be the criterion of the disease activity. While results of the test with tuberculous recombinant allergen (TRA) performed at the moment of clinical cure did not depend on the volume and severity of changes and allowed assessing the activity of the disease with any intensity of specific changes in chest lymph nodes and lung tissue, and TRA test served as a criterion of activity of mycobacterial population in the host.
About the Authors
N. A. Barmina
Clinical Phthisiopulmonology Medical Center
Russian Federation
Russian Federation
Candidate of Medical Sciences, Deputy Chief Doctor in Reporting and Statistics,
160, Kosmonavtov Highway, Perm, 614990
L. A. Baryshnikova
N. V. Postnikov Samara Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Doctor of Medical Sciences, Deputy Chief Doctor in Therapy,
154, Novo-Sadovaya St., Samara, 443068
V. V. Reykhardt
Clinical Phthisiopulmonology Medical Center
Russian Federation
Russian Federation
Chief TB Expert of the Perm Regional Ministry of Health,
160, Kosmonavtov Highway, Perm, 614990
M. S. Zhdakaev
Clinical Phthisiopulmonology Medical Center
Russian Federation
Russian Federation
Candidate of Medical Sciences, Head Doctor,
160, Kosmonavtov Highway, Perm, 614990
D. A. Kudlay
Professional Development Institute by the Russian Federal Medical Biological Agency
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor of Healthcare Economy and Marketing Department,
15, Build.1, Gamaleya St., Moscow, 123098
References
1. Aksenova V.A. Tuberkulez u detei i podrostkov. Uchebnoye posobiye. [Tuberculosis in children and adolescents. Manual]. Moscow, 2007, 269 p.
2. Аksenova V.А., Baryshnikova L.А., Klevno N.I. Current approaches to screening of tuberculous infection in children and adolescents in Russia. Med. Soviet, 2015, no. 4, pp. 30-35. (In Russ.)
3. Kiselev V.I., Baranovskiy P.M., Pupyshev S.А. et al. New skin test for tuberculosis diagnostics based on recombinant protein of ESAT-CFP. Molekulyarnaya Meditsina, 2008, vol. 4, pp. 4-6. (In Russ.)
4. Latentnaya tuberkuleznaya infektsiya (LTI) u detey. Klinicheskie rekomendatsii. [Latent tuberculous infection (LTI) in children. Clinical recommendations]. Moscow, 2016, http://cr.rosminzdrav.ru/schema.html?id=358#/text 9
5. Poddubnaya L.V., Dubakova G.F., Litvinova I.А., Panina T.А. Characteristics of pulmonary tuberculosis in children of the elder age and adolescents with formation of significant residual changes Tuberculosis and Lung Diseases, 2016, no. 5, pp. 151. (In Russ.)
6. Slogotskaya L.V., Kochetkov Ya.А., Senchikhina O.Yu., Seltsovskiy P.P., Litvinov V.I. Changes in skin test (diaskintest) in children when assessing the activity of tuberculosis infection. Tuberculosis and Lung Diseases, 2011, no. 2, pp. 59-63. (In Russ.)
7. Tuberkulez organov dykhaniya u detey. Klinicheskie rekomendatsii. [Respiratory tuberculosis in children. Clinical recommendations]. Moscow, 2016, http://cr.rosminzdrav.ru/schema.html?id=359#/text
8. Khomenko A.G. Tuberkulyoz. Rukovodstvo po vnutrennim boleznyam. [Tuberculosis. Guidelines on internal diseases]. Moscow, Meditsina Publ., 1996, 493 p.
9. Arend S., Thijsen S., Leyten E. et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care Med., 2007, vol. 175, no. 6, pp. 618-627.
10. Chiappini E., Fossi F., Bonsignori F. et al. Utility of interferon-γ release assay results to monitor anti-tubercular treatment in adults and children. Clin. Ther., 2012, vol. 34, pp. 1041-1048.
11. Connell T., Curtis N., Ranganathan S., Buttery J. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax, 2006, vol. 61, pp. 616-620.
12. Kampmann B., Whittaker E., Williams A. et al. Interferon- release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur. Respir. J., 2009, vol. 33, pp. 1371-1379.
13. Mack U., Migliori G., Sester M. et al. LTBI: latent tuberculosis infection or lasting immune responses to Mycobacterium tuberculosis? A TBNET consensus statement. Eur. Respir. J., 2009, vol. 33, pp. 956-973.
14. Menzies D., Pai M., Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med., 2007, vol. 146, pp. 340-354.
15. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med., 2008, vol. 149, no. 3, pp. 177-184.
Review
For citations:
Barmina N.A., Baryshnikova L.A., Reykhardt V.V., Zhdakaev M.S., Kudlay D.A. CRITERIA OF TUBERCULOSIS TREATMENT EFFICIENCY IN CHILDREN UNDER CURRENT CONDITIONS. Tuberculosis and Lung Diseases. 2017;95(10):69-74. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-10-69-74
Views:
1867
Email this article 